Personal tools

MCL coexpression mm9:1406: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001134!4.05e-13!9;UBERON:0002036!4.05e-13!9;UBERON:0002385!4.05e-13!9;UBERON:0000486!4.05e-13!9;UBERON:0007503!4.05e-13!9;UBERON:0001015!4.05e-13!9;UBERON:0002329!4.05e-13!9;UBERON:0003082!4.05e-13!9;UBERON:0003059!4.05e-13!9;UBERON:0007282!4.05e-13!9;UBERON:0004290!4.05e-13!9;UBERON:0009618!4.05e-13!9;UBERON:0000383!9.60e-12!10;UBERON:0001135!2.63e-11!3;UBERON:0004237!2.63e-11!3;UBERON:0004695!2.63e-11!3;UBERON:0002111!2.63e-11!3;UBERON:0004178!2.63e-11!3;UBERON:0007524!1.28e-10!11;UBERON:0003077!1.28e-10!11;UBERON:0007285!1.28e-10!11;UBERON:0000013!2.91e-10!3;UBERON:0002204!1.06e-08!32;UBERON:0000947!1.42e-08!4;UBERON:0001637!1.42e-08!4;UBERON:0004573!1.42e-08!4;UBERON:0003509!1.42e-08!4;UBERON:0004571!1.42e-08!4;UBERON:0010191!1.42e-08!4;UBERON:0004572!1.42e-08!4;UBERON:0005795!2.42e-07!4;UBERON:0000995!2.42e-07!4;UBERON:0000055!6.27e-07!5;UBERON:0007500!6.27e-07!5;UBERON:0001981!6.27e-07!5;UBERON:0002049!6.27e-07!5;UBERON:0007798!6.27e-07!5;UBERON:0004537!6.27e-07!5;UBERON:0006965!6.27e-07!5;UBERON:0001987!7.20e-07!2;UBERON:0003124!7.20e-07!2;UBERON:0004340!7.20e-07!2
|ontology_enrichment_uberon=UBERON:0001134!4.05e-13!9;UBERON:0002036!4.05e-13!9;UBERON:0002385!4.05e-13!9;UBERON:0000486!4.05e-13!9;UBERON:0007503!4.05e-13!9;UBERON:0001015!4.05e-13!9;UBERON:0002329!4.05e-13!9;UBERON:0003082!4.05e-13!9;UBERON:0003059!4.05e-13!9;UBERON:0007282!4.05e-13!9;UBERON:0004290!4.05e-13!9;UBERON:0009618!4.05e-13!9;UBERON:0000383!9.60e-12!10;UBERON:0001135!2.63e-11!3;UBERON:0004237!2.63e-11!3;UBERON:0004695!2.63e-11!3;UBERON:0002111!2.63e-11!3;UBERON:0004178!2.63e-11!3;UBERON:0007524!1.28e-10!11;UBERON:0003077!1.28e-10!11;UBERON:0007285!1.28e-10!11;UBERON:0000013!2.91e-10!3;UBERON:0002204!1.06e-08!32;UBERON:0000947!1.42e-08!4;UBERON:0001637!1.42e-08!4;UBERON:0004573!1.42e-08!4;UBERON:0003509!1.42e-08!4;UBERON:0004571!1.42e-08!4;UBERON:0010191!1.42e-08!4;UBERON:0004572!1.42e-08!4;UBERON:0005795!2.42e-07!4;UBERON:0000995!2.42e-07!4;UBERON:0000055!6.27e-07!5;UBERON:0007500!6.27e-07!5;UBERON:0001981!6.27e-07!5;UBERON:0002049!6.27e-07!5;UBERON:0007798!6.27e-07!5;UBERON:0004537!6.27e-07!5;UBERON:0006965!6.27e-07!5;UBERON:0001987!7.20e-07!2;UBERON:0003124!7.20e-07!2;UBERON:0004340!7.20e-07!2
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.473747,0.464605,2.27918,0.346849,1.35778,0.645383,0.247459,0.7141,0.0835344,0.599767,0.632897,0.692139,0.6581,0.955327,0,0.856992,0.338549,0.232269,0.442204,0.426133,0.108444,0.657163,0.91309,0.472505,0.686615,0.223823,0.572827,0.394364,1.61954,0.558142,0.960397,0.336199,0.589948,0.364821,0.951637,0.326478,0.629145,0.303703,0.27383,0.342638,1.38433,0.671603,3.53136,0.368882,0.524258,0.77511,0.589246,0.0835644,0.397446,0.839084,0.714419,0.174327,1.10437,1.12205,1.59824,0.406788,0.619643,1.15584,0.663395,0.939962,0.724164,0.269393,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.253541,0.366795,1.156,0.208101,1.08629,0.204132,0.763395,0.922432,0.430551,0.254777,0.874787,0.722675,1.25583,1.03903,0.0539203,0.0610418,0.534643,0.780154,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.769162,0.685716,0.976308,0.775372,0.160254,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,0.484547,1.0885,0.431734,0.605144,1.33732,0.90315,0.0704207,0.53982,0.858327,0.862623,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.356163,1.06946,0.52828,1.2285,0.679647,1.35909,0.106956,0.500709,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.348692,0.183562,0.0987301,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,0.48935,1.25034,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,0.325308,0.63125,0.0323861
}}
}}

Revision as of 19:51, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr17:87500395..87500399,-p@chr17:87500395..87500399
-
Mm9::chr1:157626226..157626231,-p@chr1:157626226..157626231
-
Mm9::chr7:50664622..50664632,+p@chr7:50664622..50664632
+
Mm9::chr7:50664633..50664643,+p@chr7:50664633..50664643
+
Mm9::chr7:50664666..50664671,+p@chr7:50664666..50664671
+
Mm9::chr7:50664779..50664790,+p@chr7:50664779..50664790
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
skeletal muscle tissue4.05e-139
striated muscle tissue4.05e-139
muscle tissue4.05e-139
multilaminar epithelium4.05e-139
epithelial vesicle4.05e-139
musculature4.05e-139
somite4.05e-139
myotome4.05e-139
presomitic mesoderm4.05e-139
presumptive segmental plate4.05e-139
dermomyotome4.05e-139
trunk paraxial mesoderm4.05e-139
musculature of body9.60e-1210
smooth muscle tissue2.63e-113
blood vessel smooth muscle2.63e-113
arterial system smooth muscle2.63e-113
artery smooth muscle tissue2.63e-113
aorta smooth muscle tissue2.63e-113
dense mesenchyme tissue1.28e-1011
paraxial mesoderm1.28e-1011
presumptive paraxial mesoderm1.28e-1011
sympathetic nervous system2.91e-103
musculoskeletal system1.06e-0832
aorta1.42e-084
artery1.42e-084
systemic artery1.42e-084
arterial blood vessel1.42e-084
systemic arterial system1.42e-084
aortic system1.42e-084
arterial system1.42e-084
embryonic uterus2.42e-074
uterus2.42e-074
vessel6.27e-075
epithelial tube open at both ends6.27e-075
blood vessel6.27e-075
vasculature6.27e-075
vascular system6.27e-075
blood vasculature6.27e-075
vascular cord6.27e-075
placenta7.20e-072
chorion7.20e-072
allantois7.20e-072


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}